Author

S. Provencher

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Organism:rat· 1

Frequent Co-Authors

S. Bonnet· 2 shared S. Martineau· 2 shared A. Bourgeois· 1 shared C. Romanet· 1 shared C. Theberge· 1 shared E. Dumais· 1 shared F. Potus· 1 shared G. A. Fishbein· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

S. Bonnet

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

RV-specific Targeting of Snai1 Rescues Pulmonary Hypertension-induced Right Ventricular Failure by Inhibiting EndMT and Fibrosis via LOXL2 Mediated Mechanism

S. Banerjee, V. R. C. Onwunyi, J. Hong, S. Martineau, G. A. Fishbein, S. B. Bonnet, S. Provencher, S. Bonnet, S. Umar

This study shows that targeting Snai1 in the right ventricle rescues pulmonary hypertension-induced failure by reducing EndMT, fibrosis, and FMT through a LOXL2-dependent mechanism.

bioRxiv · Apr 30, 2024 · PreprintPhysiology

ATP Citrate Lyase Drives Vascular Remodeling Diseases Development Through Metabolic-Epigenetic Reprograming.

Y. Grobs, C. Romanet, S.-E. Lemay, A. Bourgeois, P. Voisine, C. Theberge, M. Sauvaget, S. Breuils-Bonnet, S. Martineau, R. El-kabbout, M. Mougin, E. Dumais, J. Perron, N. Flamand, F. Potus, , s. Bonnet

This study identifies ATP-citrate lyase as a driver of vascular remodeling in pulmonary hypertension and coronary artery disease, showing its inhibition can reverse pathological changes.

bioRxiv · Feb 2, 2024 · PreprintPhysiology